$0.73
-0.02 (-2.68%)
Open$0.75
Previous Close$0.75
Day High$0.76
Day Low$0.72
52W High$605.00
52W Low$240.00
Volume—
Avg Volume62.3K
Market Cap132.99M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,372.6% upside
Current
$0.73
$0.73
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 900.48M | 875.69M | 56.95M |
| Net Income | -255,594,057 | -223,703,832 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -181,457,946 | -167,640,813 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.51 | 0.51 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |